At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non-Randomized Controlled Cross-Sectional Study to Compare Genetic Variations of IGF-I and IGF-II in Patients With Moderate to Severe Dementia and Younger Family Members, in Relation to Age-Matched Unaffected Controls
Avera McKennan Hospital & University Health Center·observational·Posted Apr 6, 2011·Updated Oct 6, 2011
In Brief
An observational study for Dementia. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of the AD patients and individuals without AD matched by age to the AD patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDementia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
First PostedApr 2011
Primary CompletionOct 2011
TodayJul 2026
First PostedApr 6, 2011
Enrollment StartNov 1, 2010
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.2 years ago